SCHEMBL5846237

SCHEMBL5846237

O=C1c2ccccc2C2CCCCCCC12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.54
LMNA P02545 2/20 0.51
TSHR P16473 1/20 0.51
NOS1 P29475 3/20 0.43
ACHE P22303 2/20 0.43
BCHE P06276 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
ALDH1A1 P00352 2/20 0.41
MAPT P10636 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
ALOX12 P18054 1/20 0.41
MC4R P32245 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PTPN1 P18031 2/20 0.40
PTPRC P08575 1/20 0.40
PTPRF P10586 1/20 0.40
CDC25B P30305 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6643129 1.00 PARP1 (0.54) PARP1LMNATSHRNOS1ACHE
SCHEMBL3055056 0.98 PARP1 (0.56) PARP1LMNATSHRNOS1ACHE
SCHEMBL3055055 0.98 PARP1 (0.56) PARP1LMNATSHRNOS1ACHE
SCHEMBL5846987 0.94 PARP1 (0.51) PARP1LMNATSHRNOS1ACHE
SCHEMBL23453361 0.89 PARP1 (0.51) PARP1LMNATSHRNOS1ACHE
SCHEMBL23453360 0.89 PARP1 (0.51) PARP1LMNATSHRNOS1ACHE
SCHEMBL23453325 0.87 LMNA (0.58) PARP1LMNATSHRACHEBCHE
SCHEMBL23453324 0.87 LMNA (0.58) PARP1LMNATSHRACHEBCHE
SCHEMBL31199231 0.85 LMNA (0.60) PARP1LMNATSHRACHEBCHE
SCHEMBL11136858 0.85 LMNA (0.60) PARP1LMNATSHRACHEBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060252895-A1 Metallocene compounds and use thereof in catalysts for the polymerization of olefins BASELL TECHNOLOGY COMPANY B.V. 2006-11-09 US disclosed
US-7094847-B2 Metallocene compounds and use thereof in catalysts for the polymerization of olefins BASELL TECHNOLOGY COMPANY B.V. (NL) 2006-08-22 US disclosed
EP-0702687-B1 METALLOCENE COMPOUNDS AND USE THEREOF IN CATALYSTS FOR THE POLYMERIZATION OF OLEFINS BASELL TECHNOLOGY CO BV (NL) 2001-12-05 EP disclosed
US-20010012877-A1 Metallocene compounds and use thereof in catalysts for the polymerization of olefins MONTELL TECHNOLOGY COMPANY B.V. 2001-08-09 US disclosed
US-6211108-B1 Metallocene compounds and use thereof in catalysts for the polymerization of olefins MONTELL TECHNOLOGY COMPANY BV (NL) 2001-04-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252895-A1 Metallocene compounds and use thereof in catalysts for the polymerization of olefins CPNE4, OR10J3, ORC3 PARP1 108/4885LMNA 3701/4885TSHR 4585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.